Last reviewed · How we verify

NCT05824546

uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy

Recruiting now NA Last updated 16 May 2024
What this trial tests

NA trial testing Intervention Arm (uSINE-PAMS-technique) in Ultrasound Therapy in 50 participants. Currently enrolling.

Timeline
26 May 2023
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorNational Neuroscience Institute
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment50
Start date26 May 2023
Primary completion31 July 2024
Estimated completion31 July 2024
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National Neuroscience Institute

Who can join

Adults 21 to 105, any sex, with Ultrasound Therapy or Lumbar Puncture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the effectiveness of uSINE-PAMS technology for lumbar puncture compared to traditional landmark-based technique. uSINE is a machine-learning software designed to aid the operators in ultrasound-guided lumbar puncture while PAMS is a two-part hardware to translate data from ultrasound to accurate needle insertion and angulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. uSINE-PAMS Artificial Intelligence-Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy: A Pilot Study Report.
    Lin X, Lam MLC, Chuang DF, Yuen JYE, et al · · 2025 · PMID 40201070 · DOI 10.1212/cpj.0000000000200447

Verify or expand the search:

Other National Neuroscience Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05824546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing